Results 21 to 30 of about 105,068 (238)

Eosinophilic Esophagitis [PDF]

open access: yesEar, Nose & Throat Journal, 2005
Previously perceived as an anomaly, eosinophilic esophagitis is now frequently diagnosed by both pediatric and adult specialists including gastroenterologists, allergists, pathologists, and otolaryngologists. Research efforts initially focused on characterization of the clinical, endoscopic, and histologic features of this disorder. In the last 3 years,
S Punjab, Gupta   +3 more
openaire   +4 more sources

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Dupilumab, a fully human monoclonal antibody, blocks interleukin-4 and interleukin-13 signaling, which have key roles in eosinophilic esophagitis.
E. Dellon   +29 more
semanticscholar   +1 more source

Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976-2022: A Systematic Review and Meta-Analysis.

open access: yesClinical Gastroenterology and Hepatology, 2023
BACKGROUND AND AIMS Owing to 2018 expanded diagnostic criteria for eosinophilic esophagitis (EoE) and thus a possible increase in diagnosis, previous studies on the global incidence and prevalence of EoE may need to be updated.
Jong Woo Hahn   +20 more
semanticscholar   +1 more source

The eosinophilic esophagitis and IgG4-related disease involving the esophagus [PDF]

open access: yesТерапевтический архив, 2020
The study of eosinophilic esophagitis has become a dynamic field with an evolving understanding of the pathogenesis, diagnosis, and treatment. Immunoglobulin G4 (IgG4)-related disease exhibits systemic involvement but very rarely involves the esophagus ...
N. V. Bakulina   +5 more
doaj   +1 more source

Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders beyond Eosinophilic Esophagitis.

open access: yesJournal of Pediatric Gastroenterology and Nutrition - JPGN, 2023
INTRODUCTION Eosinophilic Gastrointestinal Disorders beyond Eosinophilic Esophagitis (non-EoE EGIDs) are rare chronic inflammatory disorders of the gastrointestinal (GI) tract.
Alexandra Papadopoulou   +25 more
semanticscholar   +1 more source

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy

open access: yesPharmaceutics, 2023
The role of type 2 inflammation has been progressively associated with many diseases, including severe asthma, atopic dermatitis, nasal polyposis, eosinophilic granulomatosis with polyangiitis, and, recently, eosinophilic esophagitis.
Diego Bagnasco   +7 more
doaj   +1 more source

One Food versus Six Food Elimination Diet Therapy for Treatment of Eosinophilic Esophagitis: A Multicenter Randomized Clinical Trial

open access: yesThe Lancet Gastroenterology and Hepatology, 2023
Summary Background: Empiric elimination diets are effective for achieving histologic remission in eosinophilic esophagitis (EoE), but randomized trials comparing diet therapies are lacking.
K. Kliewer   +29 more
semanticscholar   +1 more source

A Case of Eosinophilic Esophagitis Associated with Herpes Esophagitis in a Pediatric Patient [PDF]

open access: yesClinical Endoscopy, 2019
Eosinophilic esophagitis is a rare disease in Asian countries, but its incidence is growing rapidly in Western countries. The main pathophysiology of eosinophilic esophagitis is esophageal epithelial barrier dysfunction; disruption of the esophageal ...
Jisun Kim, Kunsong Lee, Wonae Lee
doaj   +1 more source

Efficacy of elimination diets in eosinophilic esophagitis: a systematic review and meta-analysis.

open access: yesClinical Gastroenterology and Hepatology, 2023
BACKGROUND AND AIMS Eosinophilic esophagitis (EoE) can be treated by proton-pump inhibitors, topical corticosteroids or dietary measures. This study systematically assessed the efficacy of four major dietary treatment regimens in EoE, updating the ...
C. Mayerhofer   +5 more
semanticscholar   +1 more source

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.

open access: yesJournal of Allergy and Clinical Immunology: In Practice, 2022
BACKGROUND Transient increases in blood eosinophil counts have been observed in dupilumab clinical trials. OBJECTIVE Assessment of eosinophil counts and eosinophilia-related treatment-emergent adverse events (TEAEs) across 11 dupilumab clinical trials,
M. Wechsler   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy